S J van Dijk1, P L Molloy1, H Varinli2, J L Morrison3, B S Muhlhausler4. 1. CSIRO Animal, Food and Health Sciences, Preventative Health Flagship, North Ryde, New South Wales, Australia. 2. 1] CSIRO Animal, Food and Health Sciences, Preventative Health Flagship, North Ryde, New South Wales, Australia [2] Department of Biological Sciences, Macquarie University, North Ryde, New South Wales, Australia [3] Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. 3. Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia, Australia. 4. 1] FOODplus Research Centre, School of Agriculture Food and Wine, Waite Campus, The University of Adelaide, Adelaide, South Australia, Australia [2] Women's and Children's Health Research Institute, Adelaide, South Australia, Australia.
Abstract
BACKGROUND: Recent technological advances in epigenome profiling have led to an increasing number of studies investigating the role of the epigenome in obesity. There is also evidence that environmental exposures during early life can induce persistent alterations in the epigenome, which may lead to an increased risk of obesity later in life. METHOD: This paper provides a systematic review of studies investigating the association between obesity and either global, site-specific or genome-wide methylation of DNA. Studies on the impact of pre- and postnatal interventions on methylation and obesity are also reviewed. We discuss outstanding questions, and introduce EpiSCOPE, a multidisciplinary research program aimed at increasing the understanding of epigenetic changes in emergence of obesity. RESULTS: An electronic search for relevant articles, published between September 2008 and September 2013 was performed. From the 319 articles identified, 46 studies were included and reviewed. The studies provided no consistent evidence for a relationship between global methylation and obesity. The studies did identify multiple obesity-associated differentially methylated sites, mainly in blood cells. Extensive, but small, alterations in methylation at specific sites were observed in weight loss intervention studies, and several associations between methylation marks at birth and later life obesity were found. CONCLUSIONS: Overall, significant progress has been made in the field of epigenetics and obesity and the first potential epigenetic markers for obesity that could be detected at birth have been identified. Eventually this may help in predicting an individual's obesity risk at a young age and opens possibilities for introducing targeted prevention strategies. It has also become clear that several epigenetic marks are modifiable, by changing the exposure in utero, but also by lifestyle changes in adult life, which implies that there is the potential for interventions to be introduced in postnatal life to modify unfavourable epigenomic profiles.
BACKGROUND: Recent technological advances in epigenome profiling have led to an increasing number of studies investigating the role of the epigenome in obesity. There is also evidence that environmental exposures during early life can induce persistent alterations in the epigenome, which may lead to an increased risk of obesity later in life. METHOD: This paper provides a systematic review of studies investigating the association between obesity and either global, site-specific or genome-wide methylation of DNA. Studies on the impact of pre- and postnatal interventions on methylation and obesity are also reviewed. We discuss outstanding questions, and introduce EpiSCOPE, a multidisciplinary research program aimed at increasing the understanding of epigenetic changes in emergence of obesity. RESULTS: An electronic search for relevant articles, published between September 2008 and September 2013 was performed. From the 319 articles identified, 46 studies were included and reviewed. The studies provided no consistent evidence for a relationship between global methylation and obesity. The studies did identify multiple obesity-associated differentially methylated sites, mainly in blood cells. Extensive, but small, alterations in methylation at specific sites were observed in weight loss intervention studies, and several associations between methylation marks at birth and later life obesity were found. CONCLUSIONS: Overall, significant progress has been made in the field of epigenetics and obesity and the first potential epigenetic markers for obesity that could be detected at birth have been identified. Eventually this may help in predicting an individual's obesity risk at a young age and opens possibilities for introducing targeted prevention strategies. It has also become clear that several epigenetic marks are modifiable, by changing the exposure in utero, but also by lifestyle changes in adult life, which implies that there is the potential for interventions to be introduced in postnatal life to modify unfavourable epigenomic profiles.
Authors: Zhong-Zheng Zhu; Lifang Hou; Valentina Bollati; Letizia Tarantini; Barbara Marinelli; Laura Cantone; Allen S Yang; Pantel Vokonas; Jolanta Lissowska; Silvia Fustinoni; Angela C Pesatori; Matteo Bonzini; Pietro Apostoli; Giovanni Costa; Pier Alberto Bertazzi; Wong-Ho Chow; Joel Schwartz; Andrea Baccarelli Journal: Int J Epidemiol Date: 2010-09-15 Impact factor: 7.196
Authors: Mads Vilhelm Hollegaard; Jonas Grauholm; Bent Nørgaard-Pedersen; David Michael Hougaard Journal: Mol Genet Metab Date: 2013-02-01 Impact factor: 4.797
Authors: A Mor; S Antonsen; J Kahlert; V Holsteen; S Jørgensen; J Holm-Pedersen; H T Sørensen; O Pedersen; V Ehrenstein Journal: Int J Obes (Lond) Date: 2015-07-16 Impact factor: 5.095
Authors: I Khurana; A Kaspi; M Ziemann; T Block; T Connor; B Spolding; A Cooper; P Zimmet; A El-Osta; K Walder Journal: Int J Obes (Lond) Date: 2016-04-25 Impact factor: 5.095
Authors: Jonathan A R Gordon; Martin A Montecino; Rami I Aqeilan; Janet L Stein; Gary S Stein; Jane B Lian Journal: Curr Osteoporos Rep Date: 2014-12 Impact factor: 5.096
Authors: Ericka M Ebot; Travis Gerke; David P Labbé; Jennifer A Sinnott; Giorgia Zadra; Jennifer R Rider; Svitlana Tyekucheva; Kathryn M Wilson; Rachel S Kelly; Irene M Shui; Massimo Loda; Philip W Kantoff; Stephen Finn; Matthew G Vander Heiden; Myles Brown; Edward L Giovannucci; Lorelei A Mucci Journal: Cancer Date: 2017-07-12 Impact factor: 6.860